Literature DB >> 33064235

Effects of Quercetin on Cardiac Function in Pressure Overload and Postischemic Cardiac Injury in Rodents: a Systematic Review and Meta-Analysis.

Hawa Nordin Siti1,2, Juriyati Jalil3, Ahmad Yusof Asmadi4, Yusof Kamisah5.   

Abstract

PURPOSE: Cardiac dysfunction can occur as a sequela of a state of prolonged pressure overload and postischemic injury. Flavonoids such as quercetin may be protective against cardiovascular disease. This study aimed to systematically assess the effects of quercetin on cardiac function in pressure overload and postischemia-reperfusion injury in rodents.
METHODS: A systematic search of the literature up to May 2020 was conducted in PubMed, Ovid Medline, EBSCOhost, Scopus, and the Cochrane Library to identify relevant published studies on quercetin and cardiac function using standardized criteria. Meta-analyses were performed on animal studies of pressure overload and ischemia-reperfusion (I/R) injury.
RESULTS: The effects of quercetin on cardiac function in both models were qualitatively reported in 14 studies. The effects of quercetin in four pressure-overload model studies involving 73 rodents and eight I/R-injury model studies involving 120 rodents were quantitatively assessed by meta-analysis. Quercetin improved the overall cardiac function in both pressure overload (n = 4 studies, n = 73 rodents; SMD = - 1.50; 95% CI: - 2.66 to - 0.33; P < 0.05; I2 = 74.05%) and I/R injury (n = 8 studies, n = 120 rodents; SMD = - 1.81; 95% CI: - 3.05 to - 0.56; P < 0.01; I2 = 84.93%) models. The improvement was associated with amelioration in cardiac structure in the pressure-overload model and both systolic and diastolic functioning in the I/R-injury model.
CONCLUSION: The present meta-analysis suggested that quercetin has beneficial effects for improving cardiac left ventricular dysfunction in both pressure-overload and I/R-injury models.
© 2020. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cardiac function; Flavonoid; Left ventricular end-diastolic pressure; Postischemia-reperfusion injury; Pressure overload; Quercetin

Mesh:

Substances:

Year:  2020        PMID: 33064235     DOI: 10.1007/s10557-020-07100-y

Source DB:  PubMed          Journal:  Cardiovasc Drugs Ther        ISSN: 0920-3206            Impact factor:   3.727


  32 in total

1.  Parkia speciosa empty pod extract exerts anti-inflammatory properties by modulating NFκB and MAPK pathways in cardiomyocytes exposed to tumor necrosis factor-α.

Authors:  J S Gui; J Jalil; Z Jubri; Y Kamisah
Journal:  Cytotechnology       Date:  2019-01-01       Impact factor: 2.058

2.  Protective roles of quercetin in acute myocardial ischemia and reperfusion injury in rats.

Authors:  Hong-Bo Jin; Yong-Bin Yang; Ying-Li Song; Yong-chun Zhang; Yu-Rong Li
Journal:  Mol Biol Rep       Date:  2012-10-08       Impact factor: 2.316

3.  Quercetin Prevents In Vivo and In Vitro Myocardial Hypertrophy Through the Proteasome-GSK-3 Pathway.

Authors:  Kuixiang Chen; Mubarak Rekep; Wei Wei; Qian Wu; Qin Xue; Sujuan Li; Jiahui Tian; Quan Yi; Genshui Zhang; Guiping Zhang; Qing Xiao; Jiandong Luo; Yinghua Liu
Journal:  Cardiovasc Drugs Ther       Date:  2018-02       Impact factor: 3.727

4.  Quercetin reduces blood pressure in hypertensive subjects.

Authors:  Randi L Edwards; Tiffany Lyon; Sheldon E Litwin; Alexander Rabovsky; J David Symons; Thunder Jalili
Journal:  J Nutr       Date:  2007-11       Impact factor: 4.798

5.  Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study.

Authors:  Sarah Egert; Anja Bosy-Westphal; Jasmin Seiberl; Claudia Kürbitz; Uta Settler; Sandra Plachta-Danielzik; Anika E Wagner; Jan Frank; Jürgen Schrezenmeir; Gerald Rimbach; Siegfried Wolffram; Manfred J Müller
Journal:  Br J Nutr       Date:  2009-04-30       Impact factor: 3.718

6.  Parkia speciosa empty pod prevents hypertension and cardiac damage in rats given N(G)-nitro-l-arginine methyl ester.

Authors:  Yusof Kamisah; Japar Sidik Fadhlullah Zuhair; Abdul Hamid Juliana; Kamsiah Jaarin
Journal:  Biomed Pharmacother       Date:  2017-10-06       Impact factor: 6.529

7.  Quercetin-3-rutinoside Inhibits Protein Disulfide Isomerase by Binding to Its b'x Domain.

Authors:  Lin Lin; Srila Gopal; Anish Sharda; Freda Passam; Sheryl R Bowley; Jack Stopa; Guangpu Xue; Cai Yuan; Barbara C Furie; Robert Flaumenhaft; Mingdong Huang; Bruce Furie
Journal:  J Biol Chem       Date:  2015-08-03       Impact factor: 5.157

Review 8.  Left ventricular global systolic function assessment by echocardiography.

Authors:  Suresh Chengode
Journal:  Ann Card Anaesth       Date:  2016-10

9.  Effects of a quercetin-rich onion skin extract on 24 h ambulatory blood pressure and endothelial function in overweight-to-obese patients with (pre-)hypertension: a randomised double-blinded placebo-controlled cross-over trial.

Authors:  Verena Brüll; Constanze Burak; Birgit Stoffel-Wagner; Siegfried Wolffram; Georg Nickenig; Cornelius Müller; Peter Langguth; Birgit Alteheld; Rolf Fimmers; Stefanie Naaf; Benno F Zimmermann; Peter Stehle; Sarah Egert
Journal:  Br J Nutr       Date:  2015-09-02       Impact factor: 3.718

Review 10.  Quercetin, Inflammation and Immunity.

Authors:  Yao Li; Jiaying Yao; Chunyan Han; Jiaxin Yang; Maria Tabassum Chaudhry; Shengnan Wang; Hongnan Liu; Yulong Yin
Journal:  Nutrients       Date:  2016-03-15       Impact factor: 5.717

View more
  1 in total

1.  Rutin Modulates MAPK Pathway Differently from Quercetin in Angiotensin II-Induced H9c2 Cardiomyocyte Hypertrophy.

Authors:  Hawa Nordin Siti; Juriyati Jalil; Ahmad Yusof Asmadi; Yusof Kamisah
Journal:  Int J Mol Sci       Date:  2021-05-11       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.